Cargando…

Estimating the sample size of sham-controlled randomized controlled trials using existing evidence

Background: In randomized controlled trials (RCTs), the power is often ‘reverse engineered’ based on the number of participants that can realistically be achieved. An attractive alternative is planning a new trial conditional on the available evidence; a design of particular interest in RCTs that us...

Descripción completa

Detalles Bibliográficos
Autores principales: Siontis, George C.M., Nikolakopoulou, Adriani, Sweda, Romy, Mavridis, Dimitris, Salanti, Georgia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669514/
https://www.ncbi.nlm.nih.gov/pubmed/36451658
http://dx.doi.org/10.12688/f1000research.108554.2
_version_ 1784832115436683264
author Siontis, George C.M.
Nikolakopoulou, Adriani
Sweda, Romy
Mavridis, Dimitris
Salanti, Georgia
author_facet Siontis, George C.M.
Nikolakopoulou, Adriani
Sweda, Romy
Mavridis, Dimitris
Salanti, Georgia
author_sort Siontis, George C.M.
collection PubMed
description Background: In randomized controlled trials (RCTs), the power is often ‘reverse engineered’ based on the number of participants that can realistically be achieved. An attractive alternative is planning a new trial conditional on the available evidence; a design of particular interest in RCTs that use a sham control arm (sham-RCTs). Methods: We explore the design of sham-RCTs, the role of sequential meta-analysis and  conditional planning in a systematic review of renal sympathetic denervation for patients with arterial hypertension. The main efficacy endpoint was mean change in 24-hour systolic blood pressure. We performed sequential meta-analysis to identify the time point where the null hypothesis would be rejected in a prospective scenario. Evidence-based conditional sample size calculations were performed based on fixed-effect meta-analysis. Results: In total, six sham-RCTs (981 participants) were identified. The first RCT was considerably larger (535 participants) than those subsequently published (median sample size of 80). All trial sample sizes were calculated assuming an unrealistically large intervention effect which resulted in low power when each study is considered as a stand-alone experiment. Sequential meta-analysis provided firm evidence against the null hypothesis with the synthesis of the first four trials (755 patients, cumulative mean difference -2.75 (95%CI -4.93 to -0.58) favoring the active intervention)). Conditional planning resulted in much larger sample sizes compared to those in the original trials, due to overoptimistic expected effects made by the investigators in individual trials, and potentially a time-effect association. Conclusions: Sequential meta-analysis of sham-RCTs can reach conclusive findings earlier and hence avoid exposing patients to sham-related risks. Conditional planning of new sham-RCTs poses important challenges as many surgical/minimally invasive procedures improve over time, the intervention effect is expected to increase in new studies and this violates the underlying assumptions. Unless this is accounted for, conditional planning will not improve the design of sham-RCTs.
format Online
Article
Text
id pubmed-9669514
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-96695142022-11-29 Estimating the sample size of sham-controlled randomized controlled trials using existing evidence Siontis, George C.M. Nikolakopoulou, Adriani Sweda, Romy Mavridis, Dimitris Salanti, Georgia F1000Res Method Article Background: In randomized controlled trials (RCTs), the power is often ‘reverse engineered’ based on the number of participants that can realistically be achieved. An attractive alternative is planning a new trial conditional on the available evidence; a design of particular interest in RCTs that use a sham control arm (sham-RCTs). Methods: We explore the design of sham-RCTs, the role of sequential meta-analysis and  conditional planning in a systematic review of renal sympathetic denervation for patients with arterial hypertension. The main efficacy endpoint was mean change in 24-hour systolic blood pressure. We performed sequential meta-analysis to identify the time point where the null hypothesis would be rejected in a prospective scenario. Evidence-based conditional sample size calculations were performed based on fixed-effect meta-analysis. Results: In total, six sham-RCTs (981 participants) were identified. The first RCT was considerably larger (535 participants) than those subsequently published (median sample size of 80). All trial sample sizes were calculated assuming an unrealistically large intervention effect which resulted in low power when each study is considered as a stand-alone experiment. Sequential meta-analysis provided firm evidence against the null hypothesis with the synthesis of the first four trials (755 patients, cumulative mean difference -2.75 (95%CI -4.93 to -0.58) favoring the active intervention)). Conditional planning resulted in much larger sample sizes compared to those in the original trials, due to overoptimistic expected effects made by the investigators in individual trials, and potentially a time-effect association. Conclusions: Sequential meta-analysis of sham-RCTs can reach conclusive findings earlier and hence avoid exposing patients to sham-related risks. Conditional planning of new sham-RCTs poses important challenges as many surgical/minimally invasive procedures improve over time, the intervention effect is expected to increase in new studies and this violates the underlying assumptions. Unless this is accounted for, conditional planning will not improve the design of sham-RCTs. F1000 Research Limited 2022-11-07 /pmc/articles/PMC9669514/ /pubmed/36451658 http://dx.doi.org/10.12688/f1000research.108554.2 Text en Copyright: © 2022 Siontis GCM et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Method Article
Siontis, George C.M.
Nikolakopoulou, Adriani
Sweda, Romy
Mavridis, Dimitris
Salanti, Georgia
Estimating the sample size of sham-controlled randomized controlled trials using existing evidence
title Estimating the sample size of sham-controlled randomized controlled trials using existing evidence
title_full Estimating the sample size of sham-controlled randomized controlled trials using existing evidence
title_fullStr Estimating the sample size of sham-controlled randomized controlled trials using existing evidence
title_full_unstemmed Estimating the sample size of sham-controlled randomized controlled trials using existing evidence
title_short Estimating the sample size of sham-controlled randomized controlled trials using existing evidence
title_sort estimating the sample size of sham-controlled randomized controlled trials using existing evidence
topic Method Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669514/
https://www.ncbi.nlm.nih.gov/pubmed/36451658
http://dx.doi.org/10.12688/f1000research.108554.2
work_keys_str_mv AT siontisgeorgecm estimatingthesamplesizeofshamcontrolledrandomizedcontrolledtrialsusingexistingevidence
AT nikolakopoulouadriani estimatingthesamplesizeofshamcontrolledrandomizedcontrolledtrialsusingexistingevidence
AT swedaromy estimatingthesamplesizeofshamcontrolledrandomizedcontrolledtrialsusingexistingevidence
AT mavridisdimitris estimatingthesamplesizeofshamcontrolledrandomizedcontrolledtrialsusingexistingevidence
AT salantigeorgia estimatingthesamplesizeofshamcontrolledrandomizedcontrolledtrialsusingexistingevidence